EUR-Lex Search results

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Search Results

Subdomain: Parliamentary questions, EUROVOC descriptor: market approval, Search language: English
2

Written question E-004786/14 Gilles Pargneaux (S&D) to the Commission. Bisphenol A — opinion of the European Chemicals Agency (ECHA)

OJ C 435, 4.12.2014, p. 193–194 (EN, FR)

CELEX number:
92014E004786
Author:
European Parliament, Not available
Date of document:
15/04/2014; Date of transmission

Written question E-005264/14 Hiltrud Breyer (Verts/ALE) to the Commission. Scent marketing and scent allergies‐ multiple chemical sensitivity (MCS)

OJ C 426, 27.11.2014, p. 274–275 (DE, EN)

CELEX number:
92014E005264
Author:
European Parliament, Not available
Date of document:
23/04/2014; Date of transmission

Written question E-005265/14 Hiltrud Breyer (Verts/ALE) to the Commission. Homoeopathic and anthroposophic medicines

OJ C 426, 27.11.2014, p. 276–277 (DE, EN)

CELEX number:
92014E005265
Author:
European Parliament, Not available
Date of document:
23/04/2014; Date of transmission

Written question E-005505/14 Sergio Paolo Francesco Silvestris (PPE) to the Commission. Medicines and side effects on the liver

OJ C 416, 20.11.2014, p. 193–194 (EN, IT)

CELEX number:
92014E005505
Author:
European Parliament, Not available
Date of document:
24/04/2014; Date of transmission

Written question E-004785/14 Gilles Pargneaux (S&D) to the Commission. Labelling not in line with provisions on genetically modified organisms (GMO)

OJ C 402, 13.11.2014, p. 214–215 (EN, FR)

CELEX number:
92014E004785
Author:
European Parliament, Not available
Date of document:
15/04/2014; Date of transmission

Written question E-005382/14 Hiltrud Breyer (Verts/ALE) to the Commission. Co-existence and genetically modified (GM) crops

OJ C 413, 19.11.2014, p. 157–158 (DE, EN)

CELEX number:
92014E005382
Author:
European Parliament, Not available
Date of document:
23/04/2014; Date of transmission

Written question E-004915/14 Alojz Peterle (PPE) to the Commission. Marketing authorisation of homeopathic medicinal products (‘Cyprus clause’)

OJ C 405, 14.11.2014, p. 89–90 (EN, SL)

CELEX number:
92014E004915
Author:
European Parliament, Not available
Date of document:
16/04/2014; Date of transmission

Written question E-004957/14 Mara Bizzotto (EFD) to the Commission. The RU486 abortion pill

OJ C 405, 14.11.2014, p. 144–145 (EN, IT)

CELEX number:
92014E004957
Author:
European Parliament, Not available
Date of document:
16/04/2014; Date of transmission

Written question E-004659/14 Sergio Paolo Francesco Silvestris (PPE) and Oreste Rossi (PPE) to the Commission. Homeopathic medicine

OJ C 402, 13.11.2014, p. 31–32 (EN, IT)

CELEX number:
92014E004659
Author:
European Parliament, Not available
Date of document:
14/04/2014; Date of transmission

Written question E-004715/14 Roberta Metsola (PPE) to the Commission. Approval of pharmaceutical drugs by the European Medicines Agency

OJ C 402, 13.11.2014, p. 118–119 (EN, MT)

CELEX number:
92014E004715
Author:
European Parliament, Not available
Date of document:
15/04/2014; Date of transmission
2